|Bid||49.74 x 900|
|Ask||49.76 x 1100|
|Day's Range||49.60 - 50.19|
|52 Week Range||48.28 - 78.32|
|PE Ratio (TTM)||9.26|
|Forward Dividend & Yield||1.91 (3.79%)|
|1y Target Est||N/A|
Pharmacies get 'Amazoned'. What does it mean to their stocks down the road? With CNBC's Bob Pisani and Melissa Lee, and the Fast Money traders, Tim Seymour, Karen Finerman, Dan Nathan and Brian Kelly.
McKesson Corp, Cardinal Health Inc. and other distributors of opioid painkillers must face claims they fueled a public health crisis by wrongfully shipping millions of opioid painkillers to retailers and pharmacies in New York. New York Judge Jerry Garguilo Tuesday rejected the drug distributors’ bids to have some counties’ and cities’ lawsuits aimed at recouping the costs of fighting the opioid epidemic thrown out. The same judge rebuffed identical dismissal requests last month from opioid makers including Purdue Pharma LLP and Johnson & Johnson.
Now, with the e-commerce giant is reportedly in talks with a startup called Xealth and at least two hospital networks, Morgan Stanley's Brian Nowak argues that we have the next insight into Amazon's health-care strategy. Amazon is said to be talking with Xealth and others about a pilot project that would allow doctors to pre-fill a basket of over-the-counter medical supplies that would be delivered to patients' homes after they're discharged from hospitals. In addition, Nowak writes, Amazon's posted a job opening for a position to lead outreach to medical-products manufacturers and service providers, first in the U.S. and then internationally.
Bigger isn’t always better when it comes to dividends. Most readers are already familiar with this group of 53 names within the S&P 500 index, many paying out billions of dividends each quarter, with the most common trait being they’ve each boosted payouts a minimum of 25 consecutive years. An annual payout increase of a penny or two may produce a positive headline and keep you in the Aristocrat club another year, but these three names are barely treading water against other income investments and certainly not keeping up with the 7.2% average year-to-date dividend growth in the S&P 500.
Stocks continue to get more expensive despite the trade war headwinds investors face in the weeks ahead. With earnings season upon us, investors naturally will be looking to see which companies are easily beating earnings estimates before laying down their bets.
The deal's potential to disrupt major players across the drug supply chain nationwide prompted a sell-off in shares of possible rivals, while sending Amazon shares up 2.5 percent. PillPack supplies pre-sorted prescription drugs and other services to people who take multiple medications, a growing market as the U.S. population ages and requires treatment for multiple complex, chronic conditions.
Amazon.com Inc said on Thursday that it would buy medications-by-mail company PillPack for an undisclosed amount, sending shares of drug distributors and drug retailers down. Privately held PillPack delivers ...
Important news for shareholders and potential investors in Cardinal Health Inc (NYSE:CAH): The dividend payment of US$0.48 per share will be distributed into shareholder on 15 July 2018, and theRead More...
"Dividend Aristocrats" are S&P 500 stocks that meet certain minimum size and liquidity requirements and have at least 25+years of consecutive dividend increases. Through its flagship Walgreens chain and certain joint ventures, the company has a presence in more than 25 countries and employs over 385,000 people. WBA's 42 years of consecutive dividend increases qualify it as a Dividend Aristocrat, and the company appears positioned to deliver $5.95 of adjusted earnings per share for fiscal 2018.
Over the past 10 years Cardinal Health Inc (NYSE:CAH) has returned an average of 2.00% per year from dividend payouts. The company is currently worth US$16.81b, and now yields roughlyRead More...
Cardinal Health Inc (NYSE:CAH) is a stock with outstanding fundamental characteristics. When we build an investment case, we need to look at the stock with a holistic perspective. In theRead More...
Cardinal Health (CAH) intends to boost its acute-care program platform by jointly investing in the earlier acquired naviHealth along with Clayton, Dubilier & Rice.
Cardinal Health has sold a 55 percent stake in its NaviHealth unit that helps hospitals save money on Medicare cases to a private equity firm. The Dublin healthcare giant had just upped its stake in the Nashville startup to 98 percent last year.
The private-equity firm will acquire a 55% ownership stake in naviHealth, while Cardinal Health will retain a 45% interest in the business.
Companies with shares expected to trade actively in Wednesday's session include AT&T, Time Warner, Comcast, 21st Century Fox, H&R Block, and Cardinal Health.
Cardinal Health Inc. shares rose nearly 3% in premarket trade on Wednesday after a Food and Drug Administration advisory committee recommended the company's stent graft system for approval. The FDA does not have to follow an advisory committee's recommendation, but often does. The product, the Incraft AAA Stent Graft System, is a repair technology for infrarenal abdominal aortic aneurysms, which occur in the lower part of the body's main artery and can be life-threatening.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week highs on June 12) ABIOMED, Inc. (NASDAQ: ABMD ) AngioDynamics, Inc. (NASDAQ: ...
utilities stocks, such as Owens & Minor and Patterson Companies, are trading at a value below what they may actually be worth. Investors can profit from the difference by investingRead More...